Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined Etanercept, GAD-alum and vitamin D treatment: an open pilot trial to preserve beta cell function in recent onset type 1 diabetes.
Ludvigsson J, Routray I, Vigård T, Hanås R, Rathsman B, Carlsson A, Särnblad S, Albin AK, Arvidsson CG, Samuelsson U, Casas R. Ludvigsson J, et al. Among authors: casas r. Diabetes Metab Res Rev. 2021 Oct;37(7):e3440. doi: 10.1002/dmrr.3440. Epub 2021 Feb 18. Diabetes Metab Res Rev. 2021. PMID: 33486892 Free article.
A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
Hals IK, Balasuriya C, Casas R, Ludvigsson J, Björklund A, Grill V. Hals IK, et al. Among authors: casas r. Diabetes Obes Metab. 2023 Nov;25(11):3400-3409. doi: 10.1111/dom.15239. Epub 2023 Aug 14. Diabetes Obes Metab. 2023. PMID: 37580967 Free article.
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol.
Ludvigsson J, Eriksson L, Nowak C, Teixeira PF, Widman M, Lindqvist A, Casas R, Lind M, Hannelius U. Ludvigsson J, et al. Among authors: casas r. BMJ Open. 2022 Oct 31;12(10):e061776. doi: 10.1136/bmjopen-2022-061776. BMJ Open. 2022. PMID: 36316084 Free PMC article.
GAD treatment and insulin secretion in recent-onset type 1 diabetes.
Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R. Ludvigsson J, et al. Among authors: casas r. N Engl J Med. 2008 Oct 30;359(18):1909-20. doi: 10.1056/NEJMoa0804328. Epub 2008 Oct 8. N Engl J Med. 2008. PMID: 18843118 Free article. Clinical Trial.
353 results